Novocure Limited (NVCR)

Oncology Corporate Profile

HQ Location

195 Commerce Way
Portsmouth, NH 3801

Company Description

Novocure is dedicated to the development of tumor treating fields (TTF) therapy, a new weapon for patients and physicians in the battle against cancer. TTF therapy is a breakthrough anti-mitotic treatment that attempts to slow or reverse tumor progression by inducing tumor cell death prior to division. Physicians deliver TTF therapy using a portable, non-invasive medical device.

Website: http://www.novocure.com/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
NovoTTF-100L System®tumor treating fields (TTF) therapy1st line metastatic Glioblastoma Multiforme (GBM)III
NovoTTF-100L System®tumor treating fields (TTF) therapy1st line metastatic Non Small Cell Lung Cancer (NSCLC)III
NovoTTF-100L System® (+ gemcitabine and nab-paclitaxel) tumor treating fields (TTF) therapyPancreatic cancerIII
NovoTTF-100L System®tumor treating fields (TTF) therapyMesotheliomaII
NovoTTF-100L System®tumor treating fields (TTF) therapyOvarian cancerII
NovoTTF-100L System®tumor treating fields (TTF) therapyBreast cancerPreclinical
NovoTTF-100L System®tumor treating fields (TTF) therapyCervical cancerPreclinical
NovoTTF-100L System®tumor treating fields (TTF) therapyColorectal cancerPreclinical
NovoTTF-100L System®tumor treating fields (TTF) therapyGastric cancerPreclinical
NovoTTF-100L System®tumor treating fields (TTF) therapyHepatocellular cell carcinoma (HCC)Preclinical
NovoTTF-100L System®tumor treating fields (TTF) therapyMelanomaPreclinical
NovoTTF-100L System®tumor treating fields (TTF) therapyRenal cell carcinomaPreclinical
NovoTTF-100L System®tumor treating fields (TTF) therapySmall-Cell Lung Cancer (SCLC)Preclinical
NovoTTF-100L System®tumor treating fields (TTF) therapyUrinary Transitional Cell CarcinomaPreclinical

View additional information on product candidates here »

Source: http://www.novocure.com/

Recent News Headlines

There are no news items to display